Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3277915
Max Phase: Preclinical
Molecular Formula: C41H63N11O12S2
Molecular Weight: 966.15
Molecule Type: Small molecule
Associated Items:
ID: ALA3277915
Max Phase: Preclinical
Molecular Formula: C41H63N11O12S2
Molecular Weight: 966.15
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C41H63N11O12S2/c1-6-21(4)34-41(64)48-25(11-12-30(42)54)37(60)50-28(17-31(43)55)38(61)51-29(40(63)46-22(5)35(58)49-26(15-20(2)3)36(59)45-18-32(44)56)19-66-65-14-13-33(57)47-27(39(62)52-34)16-23-7-9-24(53)10-8-23/h7-10,20-22,25-29,34,53H,6,11-19H2,1-5H3,(H2,42,54)(H2,43,55)(H2,44,56)(H,45,59)(H,46,63)(H,47,57)(H,48,64)(H,49,58)(H,50,60)(H,51,61)(H,52,62)/t21-,22-,25-,26-,27-,28-,29-,34-/m0/s1
Standard InChI Key: ARCZVSMLYIDZTO-ZDWBZYQISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 966.15 | Molecular Weight (Monoisotopic): 965.4099 | AlogP: -3.03 | #Rotatable Bonds: 18 |
Polar Surface Area: 382.30 | Molecular Species: BASE | HBA: 14 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: 19.84 | CX LogP: -4.08 | CX LogD: -4.08 |
Aromatic Rings: 1 | Heavy Atoms: 66 | QED Weighted: 0.07 | Np Likeness Score: 0.65 |
1. Walter R, Smith CW, Roy J, Formento A.. (1976) Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones., 19 (6): [PMID:985884] [10.1021/jm00228a017] |
2. Adachi Y, Sakimura K, Shimizu Y, Nakayama M, Terao Y, Yano T, Asami T.. (2017) Potent and selective oxytocin receptor agonists without disulfide bridges., 27 (11): [PMID:28438540] [10.1016/j.bmcl.2017.04.030] |
Source(1):